您的位置 : 首页 / Neuronal Signaling / Enkephalinase / PL265
PL265 is a preclinical, long-acting dual enkephalinase inhibitor (DENKi), with analgesic potential and has been developed as a therapeutic for control of intractable cancer pain.
18817579266
实验数据
技术信息
生物活性